People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oakbio, Inc. | — | Other | Series B | $26.6M | $106.4M | 2021 |
| IMMUTEP Ltd | — | Biotechnology | Series A | $10.7M | $18.8M | 2017 |
Russell Howard at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Russell Howard on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| KEVIN TIDWELL | 1 | 7 |
| David Tze | 1 | 2 |
| Peter Meyers | 1 | 2 |
| Albert Wong | 1 | 2 |
| Min Zhou | 1 | 1 |
| BRIAN SEFTON | 1 | 1 |
| Lucy Turnbull | 1 | 1 |
| Russell John Howard | 1 | 1 |
| Grant John Chamberlain | 1 | 1 |
| Pete John Meyers | 1 | 1 |
| Marc Voigt | 1 | 1 |
| Deanne John Miller | 1 | 1 |
| Frederic John Triebel | 1 | 1 |
| Grant Chamberlain | 1 | 1 |
| Frederic Triebel | 1 | 1 |
| Deanne Miller | 1 | 1 |
| Alex Kopelyan | 1 | 1 |
| Mila Kyriacou | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.